PAM
BNGO icon

Panagora Asset Management’s Bionano Genomics BNGO Stock Holding History

Panagora Asset Management’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-7
Closed -$11K – 2481
2019
Q2 		$11K Sell
7
-1
-13% -$2.04K ﹤0.01% 2386
2019
Q1 		$20K Buy
+8
New +$21K ﹤0.01% 2253

Other funds holding BNGO

SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Panagora Asset Management's BNGO Position: Q3 2019 in Review

Panagora Asset Management sold out of Bionano Genomics (BNGO) in Q3 2019, closing a stake of 7 shares — an estimated $11K sold.

Panagora Asset Management first reported a position in BNGO in Q1 2019 and held it in 2 quarters. The position peaked at $20K in Q1 2019. 9 funds tracked by Wall St. Rank hold BNGO as of Q3 2019.

  • Panagora Asset Management reported no remaining Bionano Genomics position as of Q3 2019 after selling out during the quarter.
  • Panagora Asset Management sold 7 Bionano Genomics shares in Q3 2019, an estimated $11K.
  • Panagora Asset Management first reported a position in Bionano Genomics in Q1 2019 and held it in 2 quarters.
  • Panagora Asset Management's Bionano Genomics position peaked at $20K in Q1 2019.
  • 9 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2019.

Based on Panagora Asset Management's 13F filing for Q3 2019, filed 12 Nov 2019.